These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11581080)

  • 1. Potassium repletion fails to interfere with reduction of serum lithium by sodium polystyrene sulfonate in mice.
    Linakis JG; Savitt DL; Trainor BJ; Young JE; Lacouture PG
    Acad Emerg Med; 2001 Oct; 8(10):956-60. PubMed ID: 11581080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium polystyrene sulfonate treatment for lithium toxicity: effects on serum potassium concentrations.
    Linakis JG; Hull KM; Lacouture PG; Lockhart GR; Lewander WJ; Maher TJ
    Acad Emerg Med; 1996 Apr; 3(4):333-7. PubMed ID: 8881542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple-dose sodium polystyrene sulfonate in lithium intoxication: an animal model.
    Linakis JG; Eisenberg MS; Lacouture PG; Maher TJ; Lewander WJ; Driscoll JL; Woolf A
    Pharmacol Toxicol; 1992 Jan; 70(1):38-40. PubMed ID: 1594533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of delayed treatment with sodium polystyrene sulfonate on serum lithium concentrations in mice.
    Linakis JG; Hull KM; Lee CM; Maher TJ; Lewander WJ; Lacouture PG
    Acad Emerg Med; 1995 Aug; 2(8):681-5. PubMed ID: 7584745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of sodium polystyrene sulfonate for reduction of plasma lithium concentrations after chronic lithium dosing in mice.
    Linakis JG; Savitt DL; Wu TY; Lockhart GR; Lacouture PG
    J Toxicol Clin Toxicol; 1998; 36(4):309-13. PubMed ID: 9711196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of lithium elimination by multiple-dose sodium polystyrene sulfonate.
    Linakis JG; Hull KM; Lacouture PG; Lockhart GR; Lewander WJ; Maher TJ
    Acad Emerg Med; 1997 Mar; 4(3):175-8. PubMed ID: 9063542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of activated charcoal or sodium polystyrene sulfonate (Kayexalate) as gastric decontamination for lithium intoxication: an animal model.
    Linakis JG; Lacouture PG; Eisenberg MS; Maher TJ; Lewander WJ; Driscoll JL; Woolf AD
    Pharmacol Toxicol; 1989 Nov; 65(5):387-9. PubMed ID: 2622869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium absorption prevented by sodium polystyrene sulfonate in volunteers.
    Tomaszewski C; Musso C; Pearson JR; Kulig K; Marx JA
    Ann Emerg Med; 1992 Nov; 21(11):1308-11. PubMed ID: 1416323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Sodium Polystyrene Sulfonate Dosing Strategies in the Inpatient Management of Hyperkalemia.
    Mistry M; Shea A; Giguère P; Nguyen ML
    Ann Pharmacother; 2016 Jun; 50(6):455-62. PubMed ID: 27048188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of lithium toxicity with sodium polystyrene sulfonate: a retrospective cohort study.
    Ghannoum M; Lavergne V; Yue CS; Ayoub P; Perreault MM; Roy L
    Clin Toxicol (Phila); 2010 Jan; 48(1):34-41. PubMed ID: 19842945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.
    Georgianos PI; Liampas I; Kyriakou A; Vaios V; Raptis V; Savvidis N; Sioulis A; Liakopoulos V; Balaskas EV; Zebekakis PE
    Int Urol Nephrol; 2017 Dec; 49(12):2217-2221. PubMed ID: 29027620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate(®)) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency.
    Thompson K; Flynn J; Okamura D; Zhou L
    J Ren Nutr; 2013 Sep; 23(5):333-9. PubMed ID: 23707305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sodium polystyrene sulfonate on lithium bioavailability.
    Bélanger DR; Tierney MG; Dickinson G
    Ann Emerg Med; 1992 Nov; 21(11):1312-5. PubMed ID: 1416324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate.
    Lee J; Moffett BS
    Pediatr Nephrol; 2016 Nov; 31(11):2113-7. PubMed ID: 27215929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study.
    Hagan AE; Farrington CA; Wall GC; Belz MM
    Clin Nephrol; 2016 Jan; 85(1):38-43. PubMed ID: 26587776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Sodium Polystyrene Sulfonate for Short-Term Treatment of Hyperkalemia.
    Batterink J; Lin J; Au-Yeung SH; Cessford T
    Can J Hosp Pharm; 2015; 68(4):296-303. PubMed ID: 26327703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro binding of lithium using the cation exchange resin sodium polystyrene sulfonate.
    Watling SM; Gehrke JC; Gehrke CW; Zumwalt R; Pribble J
    Am J Emerg Med; 1995 May; 13(3):294-6. PubMed ID: 7755820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of sodium polystyrene sulfonate in the inpatient management of hyperkalemia.
    Kessler C; Ng J; Valdez K; Xie H; Geiger B
    J Hosp Med; 2011 Mar; 6(3):136-40. PubMed ID: 21387549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colon Necrosis Due to Sodium Polystyrene Sulfonate with and without Sorbitol: An Experimental Study in Rats.
    Ayoub I; Oh MS; Gupta R; McFarlane M; Babinska A; Salifu MO
    PLoS One; 2015; 10(9):e0137636. PubMed ID: 26413782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Damned if you do, damned if you don't: potassium binding resins in hyperkalemia.
    Watson M; Abbott KC; Yuan CM
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1723-6. PubMed ID: 20798253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.